SHENZHEN, China, June 23, 2022 /PRNewswire/ — MGI, an organization dedicated to being a world-leading life science innovator, has been awarded a Silver Globee® in the 14th Annual 2022 Golden Bridge Business and Innovation Awards® for its revolutionary COVID-19 pandemic management and response efforts worldwide.
Since the rise of COVID-19, MGI has taken an lively half in the prevention and management of the pandemic in over 70 international locations and areas worldwide, together with South Africa, Serbia, Saudi Arabia, the United Arab Emirates, Canada, and Australia.
From facilitating large-scale nucleic acid testing for the detection of the SARS-CoV-2 virus by way of offering MGI automation programs, to virus genome sequencing to tell the tracing and understanding of the epidemiology and virology of every variant, MGI’s DNBSEQ™ sequencers*, automation programs, and proprietary ATOPlex expertise have been repeatedly put to work to fight the virus and preserve communities secure.
“MGI is honored to be recognized for our innovative technology* and inclusive approach towards tackling the pandemic by the Globee® Awards,” mentioned Duncan Yu, President at MGI, “Through advanced genetic science and technology*, we are proud to support on the frontline of this important battle against COVID-19 and empower various countries and regions by supporting their genomic sequencing initiatives, enhancing their large-scale testing capability, and informing their pandemic response efforts.”
The coveted annual Golden Bridge Awards® are the world’s premier enterprise awards program honoring world achievements in each main business, with over 100 specialists from round the world taking part in the judging course of. Fellow winners embody IBM, KPMG, and Honeywell who’ve additionally been acknowledged for their enterprise excellence and cutting-edge innovation.
Amidst the ongoing battle towards COVID-19, MGI is dedicated to enjoying a key function in the detection, monitoring, surveillance, and tracing of COVID-19 and its variants to safeguard communities throughout the globe. It will proceed to work relentlessly in direction of bettering the effectivity, flexibility, and mobility of its core instruments and expertise* to satisfy ever-growing testing calls for and to succeed in extra individuals in want.
MGI Tech Co. Ltd. (MGI), headquartered in Shenzhen, is dedicated to constructing core instruments and expertise to steer life science by way of clever innovation. Based on its proprietary expertise, MGI focuses on analysis & improvement, manufacturing and gross sales of sequencing devices, reagents, and associated merchandise to assist life science analysis, agriculture, precision drugs and healthcare. MGI is a number one producer of medical high-throughput gene sequencers*, and its multi-omics platforms embody genetic sequencing*, medical imaging, and laboratory automation. MGI’s mission is to develop and promote superior life science instruments for future healthcare. For extra data, please go to the MGI web site or join with us on Twitter, LinkedIn or YouTube.
*Unless in any other case knowledgeable, StandardMPS and CoolMPS sequencing reagents, and sequencers for use with such reagents aren’t out there in Germany, USA, Spain, UK, Hong Kong, Sweden, Belgium, Italy, Finland, Czech Republic, Switzerland, Portugal, Austria, and Romania.
SOURCE MGI Tech Co., Ltd.